Navigation Links
Life Sciences Discovery Fund helps launch 3 programs to advance health research and development
Date:6/28/2011

SEATTLE, Washington, JUNE 27, 2011 The Life Sciences Discovery Fund (LSDF) today announced awards to three multi-institutional teams to support development of improved therapies and key resources for medical researchers and health-care policymakers. LSDF will allocate up to $8 million among the three programs.

The programs will be led by University of Washington investigators in partnership with collaborators across the state. Dr. David Flum will work with health-care providers, insurers, and information technology experts to create databases of clinical practices, patient outcomes, and medical costs that can be used to assess the comparative effectiveness and cost effectiveness of specific health-care strategies. This work builds upon an LSDF project grant that Dr. Flum received in 2007.

A second program, led by Dr. Michael Schwartz, will develop new human stem cell-based treatments for type 1 diabetes that avoid the problems of tumor formation and immune rejection that have previously limited the use of such therapies. The research team anticipates that their treatment approach can ultimately be applied to other diseases.

The third program, directed by Dr. John Slattery, will establish a system for collection and statewide distribution of human biological specimens required to answer important research questions and ultimately improve disease diagnosis and treatment. The specimens will be linked to biologically relevant data on the donors, and the program will be constructed to protect patient privacy and rights. This program will complement the cancer biospecimen resource that Dr. Peggy Porter of the Fred Hutchinson Cancer Research Center is developing under an LSDF 2009 program grant.

The three awards were made in the 2010 program grant competition, which supports the launch of new collaborative initiatives that address major health problems and position organizations for future competitiveness and leadership.

According to LSDF executive director Lee Huntsman, the new cohort of awards is anticipated to reap health and economic impacts that are broad in both magnitude and scope. "In addition to improving treatment of a specific conditionnamely, type 1 diabetesthese grants will create robust resources to accelerate development of diagnostics and therapies for a multitude of diseases."

Huntsman added that "the grant to Dr. Flum will allow Washington's health-care community to answer vital questions regarding the value of various treatments and determine the best uses of our limited health-care dollars."

The LSDF board of trustees selected the awardees from 11 proposals that were evaluated by national experts convened by the American Association for the Advancement of Science. In a highly competitive two-phase process, proposals were rated on scientific merit and the potential to improve health and health care in Washington and provide statewide economic benefit.

Lura Powell, chair of the LSDF board of trustees, noted that the impact of the new awards would likely be felt throughout Washington. "These grants support cutting-edge research as well as widespread distribution of high-quality specimens and health-care data. Together, they will help ensure that our state maintains its leadership position in medical research and delivery of cost-effective health care."


'/>"/>

Contact: Alden Jones
aldenj2@uw.edu
206-732-6770
Life Sciences Discovery Fund
Source:Eurekalert

Related biology news :

1. A major prize in the chemical sciences announced by the Camille and Henry Dreyfus Foundation
2. Aerospace sciences meeting to be held Jan. 5-8 in Orlando
3. Natural and social sciences: ICSU embraces the need to work more closely together
4. Energy Biosciences Institue named "Deal of Distinction" by tech-transfer group
5. Elsevier partners with the Royal Netherlands Society for Agricultural Sciences
6. The Danisco Award 2008 goes to D.Sc. Barbara Ann Halkier from Faculty of Life Sciences, Copenhagen
7. Life Sciences Discovery Fund awards health research program grants
8. Springer expands its portfolio in plant sciences with Phytoparasitica
9. Mycotoxin Research joins Springers life sciences journals program
10. NTU seals global partnerships on environmental sciences R&D
11. The Earth Observatory of Singapore devoted to the study of earth sciences officially opens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)...  Genos, a community for personal genetic discovery ... Laboratory Accreditation from the College of American Pathologists ... that meet stringent requirements around quality, accuracy and ... "Genos is committed to maintaining the highest ... to be receiving CAP accreditation," said Jill ...
(Date:2/13/2017)... -- Former 9/11 Commission border counsel and Special Counsel ... of Identity Strategy Partners, LLP, today releases the ... Order: Protecting the Nation From Foreign Terrorist Entry Into ... President Trump,s ,Travel Ban, Executive Order gains more notoriety ... travel ban, it is important that our national discourse ...
(Date:2/8/2017)... About Voice Recognition Biometrics Voice recognition biometrics ... a stored voiceprint template. Acoustic features of an ... are compared to distinguish between individual voices. Voice ... PCs already have a microphone and can authenticate ... are most likely to be deployed in telephone-based ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... Mass. , March 24, 2017 Agenus ... of immune checkpoint antibodies and cancer vaccines, today announced ... The 7 th  Annual William Blair and Maidstone Life ... Space Alexandria Center in New York, NY ... March 29 at 9:40 am: Robert ...
(Date:3/23/2017)... Diego, Calif. (PRWEB) , ... March 23, 2017 , ... Lajollacooks4u is proud to announce ... 2008, it has hosted corporate cooking challenges for companies around the world, such as Illumina, ... , Part of the reason for its increasing popularity is due to its new team ...
(Date:3/23/2017)... 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) (NW ... therapies for solid tumor cancers, today announced that ... it announced last Friday, March 17, 2017. ... investors securities totaling 28,843,692 shares, comprised of 18,843,692 ... shares of Class C Warrants pre-funded at the ...
(Date:3/23/2017)... March 23, 2017  GlobeImmune, Inc. today announced it ... sale of 12,835,490 shares of its common stock to ... companies. In connection with the sale of its common stock, ... and issue to GlobeImmune 200,000 shares, an estimated $2.0 ... "We are pleased to enter into this strategic ...
Breaking Biology Technology: